VU0155041

Pharmaceutical compound From Wikipedia, the free encyclopedia

VU0155041 is an experimental drug that is a positive allosteric modulator for the glutamate receptor mGluR4. In animal studies it has anti-Parkinsonian action, reduces neuropathic pain such as allodynia, and counteracts the effects of opioid addiction.[1][2][3][4][5][6][7][8][9]

CAS Number
Quick facts Identifiers, CAS Number ...
VU0155041
Identifiers
  • (1R,2S)-2-[(3,5-dichlorophenyl)carbamoyl]cyclohexane-1-carboxylic acid
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
ChEMBL
Chemical and physical data
FormulaC14H15Cl2NO3
Molar mass316.18 g·mol−1
3D model (JSmol)
  • C1CC[C@H]([C@H](C1)C(=O)NC2=CC(=CC(=C2)Cl)Cl)C(=O)O
  • InChI=1S/C14H15Cl2NO3/c15-8-5-9(16)7-10(6-8)17-13(18)11-3-1-2-4-12(11)14(19)20/h5-7,11-12H,1-4H2,(H,17,18)(H,19,20)/t11-,12+/m0/s1
  • Key:VSMUYYFJVFSVCA-NWDGAFQWSA-N
Close

References

Related Articles

Wikiwand AI